PHINIA Raises 2026 Outlook After Third-Quarter Adjusted EPS of $1.83
Key Facts
PHINIA raised its 2026 financial outlook after reporting third-quarter adjusted earnings of $1.83 per share, compared with $1.59 in the same period a year earlier, according to a company statement cited by StockTitan. Net income was $67 million, or $1.80 per diluted share, while adjusted earnings totaled $68 million. Establishment Labs, meanwhile, reported mixed quarterly results, with revenue above analysts’ estimates but earnings per share below them. The company reported EPS of -$0.35 against an estimate of -$0.26, and revenue of $71.99 million against expectations of $66.79 million. The results came as both companies prepared to review them with investors on calls scheduled for Oct. 29.
PHINIA’s quarterly sales were $912 million, up 0.4% year over year, but sales were flat excluding the impact of foreign currencies, according to the company statement. PHINIA attributed the improvement in adjusted operating profitability to higher sales volumes in the Americas and the timing of tariff recovery mechanisms. Adjusted earnings before interest, taxes, depreciation and amortization rose by $2 million to $135 million. The measure’s margin was 14.8%, up 20 basis points from a year earlier. The figures show improved earnings and margins in a quarter that saw little growth in underlying sales after excluding currency effects.
PHINIA had $813 million in available liquidity on Sept. 30, including $436 million in cash and equivalents and $377 million available under its revolving credit facility. Total debt was $1.1 billion at the end of the third quarter, while the company reported net leverage of 1.3 times. The figures offer a view of the company’s cash resources and obligations as it updated its full-year outlook. PHINIA said its third-quarter earnings review call would begin on Oct. 29 at 8:30 a.m. Eastern time. Establishment Labs set its call for the same date and time, according to investor relations data and its earnings announcement.
For Establishment Labs, third-quarter revenue came in above published estimates, but its per-share loss was greater than expected. The gap between actual EPS and analysts’ estimate was $0.09, while actual revenue exceeded the estimate by more than $5 million. Second-quarter results provide context for comparison: the company reported revenue of $67.5 million, up 31.7% year over year and 12.8% from the first quarter of 2026. Gross margin also rose to 70.6% from 68.8% in the second quarter of the previous year. This comparison puts third-quarter revenue above the second-quarter level, while the basis of comparison differs between the quarterly results and estimates.
Establishment Labs had raised its fiscal 2026 revenue outlook when it reported second-quarter results, to a range of $269 million to $271 million from $266.5 million to $268.5 million previously. Chief Executive Peter Caldini said at the time that the company expected “strong growth in the second half of 2026 and throughout 2027.” He added that the business was tracking toward high growth and positive free cash flow. The earlier outlook increase followed second-quarter results, revenue growth and an improvement in gross margin. The next announced opportunity to discuss both companies’ results was their Oct. 29 calls, each at 8:30 a.m. Eastern time.
In stock trading, Establishment Labs closed at $68.97 on Oct. 28, 2026, up 3.02% from the previous close, according to investor relations data. The available PHINIA record showed its shares closing at $57.68 on the same date. The PHINIA data cited here are limited to the closing price and do not include a verified session high. Both closing prices came ahead of the earnings calls scheduled for the following day. The available data did not include a verified daily move for PHINIA shares.